Wolfgang Fischer
Direttore operativo presso AFFIMED N.V.
Patrimonio netto: 710 221 $ in data 30/04/2024
Posizioni attive di Wolfgang Fischer
Società | Posizione | Inizio | Fine |
---|---|---|---|
AFFIMED N.V. | Direttore operativo | 13/09/2017 | - |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Direttore operativo | 01/01/2017 | - |
Storia della carriera di Wolfgang Fischer
Precedenti posizioni note di Wolfgang Fischer
Società | Posizione | Inizio | Fine |
---|---|---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | 01/01/2003 | - |
Formazione di Wolfgang Fischer
Swiss Federal Institute of Technology | Doctorate Degree |
University of Würzburg Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 4 |
Svizzera | 3 |
Posizioni
Chief Operating Officer | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 1 |
Settori
Consumer Services | 3 |
Commercial Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AFFIMED N.V. | Health Technology |
Aziende private | 2 |
---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
- Borsa valori
- Insiders
- Wolfgang Fischer
- Esperienza